Open House biologic discount contracts 2026-23 - Darbepoetin alfa
Original notice title
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026-23 - Darbepoetin alfa
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
30 / 100
Risk factors
The open house procedure is not subject to standard procurement law; legal recourse is limited to social courts.
No estimated value or framework maximum provided – uncertain volume.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 3 lots
- Duration until Jul 2028
- Conclusion of discount agreements (Rabattverträge) for Darbepoetin alfa with TK.
- Three lots based on strength: excluding 300µg/500µg, 300µg, and 500µg.
Show full summary
Open House procedure by Techniker Krankenkasse (TK) for discount agreements on Darbepoetin alfa, divided into three lots by strength (excluding 300µg/500µg, 300µg, 500µg). The procedure is not a traditional public procurement but an open house under §130a Abs. 8 SGB V, where all eligible pharmaceutical entrepreneurs meeting the stated conditions will be accepted. No estimated value is provided. The contract runs from 01.08.2026 to 31.07.2028, with continuous entry possible. Submission is via email (with qualified electronic signature) or post; electronic submission via the portal is not allowed. Award is based solely on eligibility; no price competition or other award criteria are applied.
Risks
The open house procedure is not subject to standard procurement law; legal recourse is limited to social courts.
No estimated value or framework maximum provided – uncertain volume.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur as per §4 Abs. 18 AMG for the offered medicinal product.
- Must have valid marketing authorization or be entitled to place the product on the market.
Eligibility
- Must provide a self-declaration (Anlage 4) confirming eligibility and reliability.
Requirements may be incomplete.
Buyer
Location
Hamburg, DEU
Website
Identifier
992-80116-93
Activity
Health
Lots (3)
LOT-0001
Darbepoetin alfa (excluding 300µg or 500µg)
Rabattverträge for Darbepoetin alfa excluding strengths 300µg and 500µg. Performance in Germany (DE600).
Location
Duration
Category
Award details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Darbepoetin alfa zu schließen.
Value note
Show original TED data
Original lot title
Darbepoetin alfa (exkl. Wirkstärken mit 300µg oder 500µg)
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Darbepoetin alfa zu schließen.
LOT-0002
Darbepoetin alfa (strength 300µg)
Rabattverträge for Darbepoetin alfa strength 300µg. Performance in Germany (DE600).
Location
Duration
Category
Award details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Darbepoetin alfa zu schließen.
Value note
Show original TED data
Original lot title
Darbepoetin alfa (Wirkstärke 300µg)
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Darbepoetin alfa zu schließen.
LOT-0003
Darbepoetin alfa (strength 500µg)
Rabattverträge for Darbepoetin alfa strength 500µg. Performance in Germany (DE600).
Location
Duration
Category
Award details
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Darbepoetin alfa zu schließen.
Value note
Show original TED data
Original lot title
Darbepoetin alfa (Wirkstärke 500µg)
Original TED description
Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130a Abs. 8 SGB V zu dem Wirkstoff Darbepoetin alfa zu schließen.
Procurement Details
- Publication date
- 04 Jun 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 387146-2026
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
30 / 100
Risk factors
The open house procedure is not subject to standard procurement law; legal recourse is limited to social courts.
No estimated value or framework maximum provided – uncertain volume.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications